SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:145353175"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:145353175" > What Should Clinici...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus

Evers, AWM (author)
Colloca, L (author)
Blease, Charlotte (author)
General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA
show more...
Gaab, J (author)
Jensen, KB (author)
Karolinska Institutet
Atlas, LY (author)
Beedie, CJ (author)
Benedetti, F (author)
Bingel, U (author)
Buchel, C (author)
Bussemaker, J (author)
, en Colagiuri (author)
Crum, AJ (author)
Finniss, DG (author)
Geers, AL (author)
Howick, J (author)
Klinger, R (author)
Meeuwis, SH (author)
Meissner, K (author)
Napadow, V (author)
Petrie, KJ (author)
Rief, W (author)
Smeets, I (author)
Wager, TD (author)
Wanigasekera, V (author)
Vase, L (author)
Kelley, JM (author)
Kirsch, I (author)
show less...
 (creator_code:org_t)
2020-10-19
2020
English.
In: Psychotherapy and psychosomatics. - : S. Karger AG. - 1423-0348 .- 0033-3190. ; 90:1, s. 49-56
Related links:
https://www.karger.c...
show more...
https://doi.org/10.1...
http://kipublication...
https://doi.org/10.1...
https://urn.kb.se/re...
show less...
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • <b><i>Introduction:</i></b> Clinical and laboratory studies demonstrate that placebo and nocebo effects influence various symptoms and conditions after the administration of both inert and active treatments. <b><i>Objective:</i></b> There is an increasing need for up-to-date recommendations on how to inform patients about placebo and nocebo effects in clinical practice and train clinicians how to disclose this information. <b><i>Methods:</i></b> Based on previous clinical recommendations concerning placebo and nocebo effects, a 3-step, invitation-only Delphi study was conducted among an interdisciplinary group of internationally recognized experts. The study consisted of open- and closed-ended survey questions followed by a final expert meeting. The surveys were subdivided into 3 parts: (1) informing patients about placebo effects, (2) informing patients about nocebo effects, and (3) training clinicians how to communicate this information to the patients. <b><i>Results:</i></b> There was consensus that communicating general information about placebo and nocebo effects to patients (e.g., explaining their role in treatment) could be beneficial, but that such information needs to be adjusted to match the specific clinical context (e.g., condition and treatment). Experts also agreed that training clinicians to communicate about placebo and nocebo effects should be a regular and integrated part of medical education that makes use of multiple formats, including face-to-face and online modalities. <b><i>Conclusions:</i></b> The current 3-step Delphi study provides consensus-based recommendations and practical considerations for disclosures about placebo and nocebo effects in clinical practice. Future research is needed on how to optimally tailor information to specific clinical conditions and patients’ needs, and on developing standardized disclosure training modules for clinicians.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view